Home Tags ABBV-3373

Tag: ABBV-3373

Photo: AbbVie R&D has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology. Photo courtesy: © 2019 - 2020 AbbVie

Beyond Oncology: ABBV-3373 Shows Improvement in Disease Activity in Phase IIa...

Research linked to the development of Antibody-drug Conjugates (ADC) for the treatment of human diseases has, for decades, been focused on oncology and hematological...

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic Payloads...

Antibody-drug Conjugates or ADCs combine the selectivity of antibodies with the efficacy of small molecule drugs, allowing for more precise, targeted, therapeutic applications.Combining the...